Trinity Biotech (TRIB) and Achieve Life Sciences (ACHV) Head to Head Contrast


Trinity Biotech and Achieve Life Sciences are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends. Trinity Biotech has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500.



from Biotech News